What research peptides actually cost in Australia in 2026 — price ranges by compound class, how to work out cost per mg, and why two listings for the 'same' vial can differ by four times.
Written by the Peptide Labs Research Team
Look across five or six Australian research peptide suppliers and the same compound, in what looks like the same vial size, can be listed anywhere from under $60 to well over $200. That spread isn't noise — most of it is explained by three variables: vial size, purity grade, and whether the vendor is actually paying for third-party testing. This guide breaks down what drives price by compound class, how to compare listings properly using cost per mg rather than sticker price, and what an unusually low price is actually telling you.
Nothing below is a recommendation to buy any specific product, and none of it describes a dose, protocol or outcome. It's a buyer's-market explainer for people evaluating research peptide suppliers, written from the same synthesis-cost reasoning covered in more depth in How to Spot a Scam Peptide Supplier.
Peptide pricing clusters roughly by manufacturing difficulty, not by popularity. As a rough guide to how the market is currently priced across Australian suppliers:
| Compound class | Relative price band | Why |
|---|---|---|
| Simple short-chain peptides (e.g. BPC-157, GHK-Cu, Melanotan) | Lower | Shorter sequences, well-established synthesis routes |
| Growth-hormone-axis peptides (e.g. CJC-1295, Ipamorelin, Tesamorelin) | Mid | Longer sequences, some requiring more purification passes |
| Multi-receptor / complex peptides (e.g. Retatrutide, Tirzepatide) | Higher | Long, structurally complex sequences with lower synthesis yield |
| Blends (e.g. BPC-157 + TB-500) | Priced above either single compound, below buying both separately | You're paying for one vialling and one QC pass instead of two |
This is a *relative* map, not a live price list — vial pricing changes with input-material costs and exchange rates. For current pricing on any specific product, check the listing directly: prices shown on product pages reflect what's charged today, not a cached figure from when an article was written.
Comparing two listings by sticker price alone is misleading whenever vial sizes differ, and vial sizes differ constantly — 5mg, 10mg, 20mg, 30mg vials of the same compound are all common. The only apples-to-apples comparison is price ÷ milligrams.
Worked example (illustrative numbers, not live pricing):
| Listing | Vial size | Price | Cost per mg |
|---|---|---|---|
| Vendor A | 10mg | $150 | $15.00/mg |
| Vendor B | 20mg | $260 | $13.00/mg |
| Vendor C | 10mg | $95 | $9.50/mg |
Vendor A looks mid-priced next to Vendor B until you divide by milligrams — Vendor B is actually cheaper per unit. Vendor C looks like the bargain, and might be, but a price meaningfully below the other two on the *same* compound is the point where you should be asking why, not just clicking buy — see the next section.
Landed cost is the more complete version of this same idea: cost per mg, plus shipping, minus any discount code, gives the number that actually determines what you paid for a milligram of active compound in your hand.
Peptide synthesis has a real, physical cost floor: raw material, solid-phase synthesis, HPLC purification, lyophilisation, vialling and testing all cost money, and none of that cost disappears because a vendor wants to compete on price. When one listing sits dramatically below the rest of the market for the same compound and vial size, the explanations are limited, and none of them are "this vendor found a secret cheap source" — the synthesis houses supplying this market are largely the same ones, selling to everyone at broadly similar input costs.
How to Spot a Scam Peptide Supplier covers this in full — underfilled vials, skipped third-party testing, and recycled CoAs are the usual ways a listing gets to an unrealistic price. The short version: verify a batch-specific Certificate of Analysis before assuming a cheap vial is simply a good deal.
This pillar page is the hub for a series covering pricing on specific compounds and compound groups in detail:
Price is one input into choosing a supplier, not the only one — manufacturing standards, independent testing, and what happens if something goes wrong all matter alongside cost per mg. Two tools on this site are built for that comparison directly:
Is the cheapest listing always the worst one?
No — but a price well below the rest of the market for an identical compound and vial size is a signal to check the CoA before ordering, not a reason to trust it less automatically or more.
Does a higher price guarantee better quality?
No. Price correlates with real cost drivers (purity grade, testing, vial size) but isn't proof of anything by itself. A batch-specific CoA from an accredited lab is the actual evidence; price is a heuristic at best.
Why do prices change over time?
Input material costs, exchange rates and demand all move. That's also why this article avoids quoting fixed dollar figures — check the live listing for the current price on any specific product.
Disclaimer: All products referenced are supplied for laboratory research purposes only and are not for human or veterinary use. Nothing in this article describes a dosing protocol or outcome, and pricing figures used as worked examples are illustrative, not live quotes. Check individual product pages for current pricing.
What Retatrutide costs per vial, per mg and across the 10mg/20mg/30mg range from Australian research suppliers in 2026, and why the price doesn't scale in a straight line with vial size.
Buying GuidesWhat BPC-157 10mg vials cost from Australian research suppliers in 2026, why prices range so widely between vendors, and why research-grade vials and consumer capsule products aren't the same thing.
99%+ HPLC purity · COA verified every batch · Next-day dispatch to Melbourne
Shop All Peptides